Elastrin Therapeutics, a Greenville, SC-based biotechnology firm, raised $10M in funding.
The spherical was led by Kizoo Know-how Capital, with participation from Starbloom Capital and SC Launch.
The corporate intends to make use of the funds to develop operations and its growth efforts.
Based in 2018 as a spinout from Clemson College the place the know-how was first developed by Dr. Naren Vyavahare over a 20-year interval, and led by CEO Matthias Breugelmans, Elastrin Therapeutics is a biotech firm growing therapies to reverse heart problems. The lead asset ELT-001 is an EDTA-loaded nanoparticle conjugated with a proprietary monoclonal antibody for the therapy of vascular calcification.